RAS pathway biomarkers for breast cancer prognosis

Metastatic breast cancer is a highly heterogeneous, rapidly evolving and devastating disease that challenges our ability to find curative therapies. RAS pathway activation is an understudied research area in breast cancer. EGFR/RAS pathway activation is prevalent in breast cancer with poor prognosis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lab Int
Main Authors: Siewertsz van Reesema, Lauren L., Lee, Michael P., Zheleva, Vasilena, Winston, Janet S., O'Connor, Caroline F., Perry, Roger R., Hoefer, Richard A., Tang, Amy H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455995/
https://ncbi.nlm.nih.gov/pubmed/28579913
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados